Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Easier-To-Use Anti-Flu Inhaler In Development At Daiichi Sankyo

This article was originally published in PharmAsia News

Executive Summary

Daiichi Sankyo hopes to bring to market by the end of the fiscal year a new type of anti-influenza inhaler. The device features a built-in tank that can hold two doses of the CS-8958 drug. The patient slides the tank into the inhaler as it is held to the mouth, eliminating the need to attach a cartridge commonly used for delivering powdered medications. Comparison clinical trials already have begun to prove drug efficacy is not reduced by the new design. The CS-8958 drug itself has completed late-stage trials and is being tested against the H5N1 bird flu as well as the A and B influenzas. (Click here for more - a subscription may be required
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069944

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel